The Patent Finder

Cassiopea S.P.A.

Also on record
Records under this name other than the patents Cassiopea S.P.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 13 patents it holds.

Back to Cassiopea S.P.A.

PatentTitleStatus Expires Confidence
US 9,433,628Enzymatic Process for Obtaining 17 Alpha- Monoesters of Cortexolone And/Or Its 9,11- Dehydroderivatives
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,700,536Topical formulations of tellurium-containing compounds
Lapsed on the fee record
Ended Jul 11, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jul 11, 2025From the USPTO record
US 9,216,197Topical formulations of tellurium-containing compounds
Lapsed on the fee record
Ended Dec 22, 2023 · From the USPTO record
Lapsed on the fee recordEnded Dec 22, 2023From the USPTO record
US 8,143,24017ALPHA, 21-Dihydroxypregnene Esters as Antiandrogenic Agents
Term ended
Term ended Jan 12, 2023 · Medium confidence
Term endedTerm ended Jan 12, 2023Medium confidence
US 9,895,37917alpha, 21-dihydroxypregnene esters as antiandrogenic agents
Term ended
Term ended Sep 27, 2022 · From the USPTO record
Term endedTerm ended Sep 27, 2022From the USPTO record
US 8,865,69017ALFA, 21-Dihydroxypregnene Esters as Antiandrogenic Agents
Term ended
Ended no later than Jul 24, 2022 · Low confidence
Term endedEnded no later than Jul 24, 2022Low confidence
US 9,211,29517 alpha, 21-dihydroxypregnene esters as antiandrogenic agents
Formerly held
Term ended
Ended no later than Jul 24, 2022 · From the USPTO record
Term endedEnded no later than Jul 24, 2022From the USPTO record
US 8,703,753Use of tellurium compounds for the treatment of actinic keratosis
Lapsed on the fee record
Ended Apr 22, 2022 · From the USPTO record
Lapsed on the fee recordEnded Apr 22, 2022From the USPTO record
US 8,623,908Use of tellurium compounds for inhibition of interleukin-converting enzyme
Lapsed on the fee record
Ended Jan 7, 2022 · From the USPTO record
Lapsed on the fee recordEnded Jan 7, 2022From the USPTO record
US 6,472,381Method of treating psoriasis
Term ended
Term ended Oct 12, 2021 · From the USPTO record
Term endedTerm ended Oct 12, 2021From the USPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited